UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: March 6, 2000
Medix Resources, Inc.
(Exact name of registrant as specified in its charter)
Colorado 0-24768 84-1123311
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
7100 E. Belleview Avenue, Englewood, CO 80111
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 741-2045
None
(Former name or former address, if changes since last report)
Item 5. Other Events. Press release announcing
The resignation of one of the Company's directors.
<PAGE>
Exhibits
Exhibit 99.1 Press release dated March 6, 2000 announcing the resignation of
one of the Company's directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIX RESOURCES, INC.
Date: April 3, 2000 By: /s/ David Kinsella
David Kinsella
Secretary and Controller
R O B I N S C H O E N P U B L I C R E L A T I O N S
526 Penn Street Newtown, PA 18940 t: 215/504-2122 f: 215/504-2123
e-m: [email protected]
FOR IMMEDIATE RELEASE
March 6, 2000
Contacts: General and Press Inquiries Investor Inquiries
----------------------------- --------------------
Robin Schoen Josh Golomb
Robin Schoen Public Relations SmallCaps Online Communications
215/504-2122 212/554-4158
DR. BRIAN MCLEAN RESIGNS FROM MEDIX BOARD OF DIRECTORS
Company Files S-8 Registration
Denver, CO -- John Prufeta, CEO of Medix Resources, Inc. [OTCBB:MDIX], today
announced that Dr. Brian McLean resigned from the Medix Resources board of
directors effective Thursday March 2, 2000. The Company also filed an S-8
registration statement with the Securities and Exchange Commission on March 3,
2000.
Dr. McLean had been a director since April 1999 and an investor in Cymedix
Corporation since 1996. Dr. McLean stated personal obligations and time
constraints as the reasons for his resignation.
"We are sorry to see Dr. McLean leave the Board," stated Prufeta. "We wish him
well in his future endeavors and thank him for his service to the Company."
"Medix and its board have done a terrific job this last two years," stated Dr.
McLean. "I am honored to have served with such a distinguished group of
professionals. I look forward to the Company's continued success."
The Company also announced that it filed an S-8 registration statement with the
Securities and Exchange Commission. This filing included all employee and
director stock options issued pursuant to stock option plans and employment
agreements dating back to 1988. The total number of shares registered was
9,500,253. Currently, 8,535,253 of such shares are covered by outstanding
options
Medix Resources, through Cymedix Lynx Corporation, offers Cymedix.com, a suite
of fully-secure, patented Internet communications software products, to the
healthcare industry. Additional information about Medix Resources and its
products and services can be found by visiting its Web sites,
www.medixresources.com and www.cymedix.com, or by calling 800/326-8773.
# # #
"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995: The statements contained in this release, which are not historical facts,
contain forward-looking information with respect to plans, projections and/or
future performance of the Company, the occurrence of which involve certain risks
and uncertainties detailed in the Company's Form 10-KSB/A for 1998, which was
filed with the Securities and Exchange Commission on July 23, 1999, and its 1999
third quarter Form 10-QSB, which was filed with the Securities and Exchange
Commission on November 10, 1999. This information is available from the SEC or
the Company.
